Abstract: We investigate a multi-layer data transmission scheme with superimposed pilots (SIPs) to enhance the throughput of multiple-input multiple-output orthogonal frequency-division multiplexing ...

Residents fear data centers will raise utility bills and strain resources Local opposition unites farmers, environmentalists and homeowners across party lines Pennsylvania utilities project sharp rise ...

The increasing strain on the power grid from the rapid buildout of new data centers in Virginia is going to push your utility bills up the next two years, with a small bit of good news. OK, so, this ...

Nassau County Executive Bruce Blakeman joined Long Island families Monday in leading a push to add gluten warnings to add packaged foods and restaurant menus across the country. Blakeman, who is ...

RedStone announces launch of its first Push oracle on GIWA testnet today, November 19, 2025. GIWA now supports both push and 300+ Pull feeds. RED token price surged by 0.8% after the announcement was ...

Where Microsoft promises enterprises better understanding of their data for workers and autonomous agents alike, analysts fear deployment hurdles and vendor lock-in. With Fabric IQ, Microsoft is ...

The Ethereum Foundation shared a new proposal that could alter how L2s and users interact by eliminating intermediaries. The initiative is being led by the Ethereum Foundation and the ERC-4337 team.

The proposed Hermantown Data Center has a variety of potential impacts, both positive and negative. Proponents are excited by the prospect of economic development and job creation, while those opposed ...

At least 16 data center projects, worth a combined $64 billion, have been blocked or delayed as local opposition mounts to the developments, according to a new study. Research collected by Data Center ...

While many companies are interested in adopting a data fabric architecture, organizations don't realize that the essence of a true data fabric leverages embedded AI with a unified semantic layer for ...

Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease market served by Alnylam Pharmaceuticals, BridgeBio and Pfizer. The phase 2 trial compared two doses of ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...